identified articles. Topic experts and organisations were also contacted.
Study selection Only randomised controlled trials were considered and there were no restrictions regarding language or date of publication.
Data extraction and synthesis Data abstraction and risk of bias assessment were conducted in duplicate and Cochrane statistical guidelines were followed. The GRADE tool was used to assess the quality of the body of evidence.
Results Twenty-one trials with 2570 participants were included.
Eighteen trials (2376 participants) related to prevention and three to treatment (194 participants). Six studies were at high risk of bias, 14 of unclear risk and one study at low risk.
There was moderate evidence (four trials, 750 participants) that chlorhexidine mouthrinses (0.12% and 0.2% concentrations) both before and after extraction(s) prevented approximately 42% of dry socket(s) with a RR of 0.58 (95% CI 0.43 to 0.78; P < 0.001). The number of patients needed to be treated (0.12% and 0.2%) with chlorhexidine rinse to prevent one patient having dry socket (NNT) was 232 (95% CI 176 to 417), 47 (95% CI 35 to 84) and 8 (95% CI 6 to 14)
at prevalences of dry socket of 1%, 5% and 30% respectively. to 154) and 6 (95% CI 5 to 26) at prevalences of dry socket of 1%, 5% and 30% respectively. There was insufficient evidence to determine the effects of other intrasocket preventive interventions or interventions to treat dry socket.
Conclusions There is some evidence that rinsing with chlorhexidine (0.12% and 0.2%) or placing chlorhexidine gel (0.2%) in the sockets
3A| 2C| 2B| 2A| 1B| 1A|
Question: What is the effectiveness of local interventions used for the prevention and treatment of dry socket?
Commentary
In this particular review, the authors have undertaken the analysis of a very difficult topic, the prevention and treatment of alveolar osteitis (AO) using local measures. `While most clinicians know AO when they see one, for purposes of analysis, the working definition can be quite variable, making comparisons across studies difficult.
The reported frequencies of AO range from 0 -37.5%. The wide range of estimates may be due to differences in the studies' working definition of AO. In this report, diagnostic criteria for AO were not listed. Each study included had the diagnostic criteria agreed upon prospectively. It is not clear, however, that the definitions of AO were the same across studies, and combining data may not be appropriate. Given the unknown frequency of AO, a strength of this review was estimating the treatment effect across several possible frequencies of AO, ie 1%, 5%, and 30%.
The results of this study suggest that the use of chlorhexidine mouthrise or intrasocket application have a minimal to marked effect on decreasing the frequency of AO, ie the number needed to treat ranged from 232 (mouthrinse at a 1% prevalence of AO) to six (intrasocket application at a 30% prevalence of AO). Despite the authors' cautions to the contrary, which seems overestimated This paper is based on a Cochrane Review published in the Cochrane Library 2011, issue 12 (see www.thecochranelibrary.com for information). Cochrane Reviews are regularly updated as new evidence emerges and in response to feedback, and the Cochrane Library should be consulted for the most recent version of the review. 
